Drug intelligence / Profile preview

M041

Development stage
Preclinical
Lead developer
M6P Therapeutics
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

M041 is a preclinical-stage recombinant enzyme replacement therapy (ERT) being developed by M6P Therapeutics for the treatment of Sanfilippo B syndrome (MPS IIIB). The therapy consists of a human alpha-N-acetylglucosaminidase (NAGLU) enzyme engineered with high levels of mannose 6-phosphate (M6P) to enhance its uptake into cells via M6P receptors. This increased phosphorylation is achieved through the company's proprietary S1S3 bicistronic expression platform, which co-expresses NAGLU with the S1S3 enzyme (GlcNAc-1-phosphotransferase). By restoring NAGLU activity in the lysosomes, M041 aims to degrade accumulated heparan sulfate, potentially slowing or reversing the neurodegeneration and other clinical manifestations associated with MPS IIIB.

Other names
NAGLUM6PNAGLUM-6PNAGLUM 6Pphosphorylated alpha-N-acetylglucosaminidase
02

Targets

IGF2R (Cation-independent mannose-6-phosphate receptor)HS (Heparan sulfate)NAGLU (Alpha-N-acetylglucosaminidase)

Beyond the preview

Go deeper on M041.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call